rs5911556

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_000828.5(GRIA3):​c.269-21217C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0174 in 111,508 control chromosomes in the GnomAD database, including 24 homozygotes. There are 517 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.017 ( 24 hom., 517 hem., cov: 23)

Consequence

GRIA3
NM_000828.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.103

Publications

1 publications found
Variant links:
Genes affected
GRIA3 (HGNC:4573): (glutamate ionotropic receptor AMPA type subunit 3) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing at this locus results in different isoforms, which may vary in their signal transduction properties. [provided by RefSeq, Jul 2008]
GRIA3 Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability 94
    Inheritance: XL Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability due to GRIA3 anomalies
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0174 (1940/111508) while in subpopulation NFE AF = 0.0266 (1412/53026). AF 95% confidence interval is 0.0255. There are 24 homozygotes in GnomAd4. There are 517 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIA3NM_000828.5 linkc.269-21217C>A intron_variant Intron 2 of 15 ENST00000622768.5 NP_000819.4 P42263-1Q17R51
GRIA3NM_007325.5 linkc.269-21217C>A intron_variant Intron 2 of 15 ENST00000620443.2 NP_015564.5 P42263-2Q17R51

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIA3ENST00000620443.2 linkc.269-21217C>A intron_variant Intron 2 of 15 1 NM_007325.5 ENSP00000478489.1 P42263-2
GRIA3ENST00000622768.5 linkc.269-21217C>A intron_variant Intron 2 of 15 5 NM_000828.5 ENSP00000481554.1 P42263-1

Frequencies

GnomAD3 genomes
AF:
0.0174
AC:
1939
AN:
111454
Hom.:
23
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00378
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00114
Gnomad FIN
AF:
0.0344
Gnomad MID
AF:
0.00847
Gnomad NFE
AF:
0.0266
Gnomad OTH
AF:
0.0187
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0174
AC:
1940
AN:
111508
Hom.:
24
Cov.:
23
AF XY:
0.0153
AC XY:
517
AN XY:
33822
show subpopulations
African (AFR)
AF:
0.00378
AC:
116
AN:
30725
American (AMR)
AF:
0.0122
AC:
128
AN:
10510
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
44
AN:
2635
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3548
South Asian (SAS)
AF:
0.00114
AC:
3
AN:
2628
European-Finnish (FIN)
AF:
0.0344
AC:
207
AN:
6016
Middle Eastern (MID)
AF:
0.00930
AC:
2
AN:
215
European-Non Finnish (NFE)
AF:
0.0266
AC:
1412
AN:
53026
Other (OTH)
AF:
0.0184
AC:
28
AN:
1521
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
69
137
206
274
343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0222
Hom.:
270
Bravo
AF:
0.0155

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
1.7
DANN
Benign
0.65
PhyloP100
-0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5911556; hg19: chrX-122365937; API